Back to search
Conjunctival Neoplasms
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Conjunctival Neoplasms trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Conjunctival Neoplasms trials you may qualify forThis phase I trial studies the safety of personalized neo-antigen peptide vaccine in treating patients with stage IIIC-IV melanoma, hormone receptor positive HE…
The goal of this observational study is to conduct a prospective assessment of the individual Burden of 9 rare skin diseases to assess disability in the broades…
The investigators were interested in pigmented tumours of the anterior segment of the eye in children because there is very little data on their evolution. The…
The study involves enrollment of patients with sebaceous carcinoma, Merkel's carcinoma, Porocarcinoma, Melanoma, and squamous cell Ca of the ocular surface and…
The purpose of this first in human study is to evaluate the feasibility, safety, and efficacy of administering TBio-4101 (tumor infiltrating lymphocytes \[TIL\]…
The purpose of this study is to determine the maximum tolerated dose of imatinib mesylate, given in association with a fixed dose of cyclophosphamide (50 mg bid…